Abstract
Recently, more and more studies have found that pain generation, transmission and modulation are under hormonal regulation. Indeed, hormonal dysregulation is a common component of chronic pain syndromes. Studies have attempted to determine whether the relationship between the pain and its perception and hormones is a causative relationship and how these processes interrelate. This review summarizes and analyzes the current experimental data and provides an overview of the studies addressing these questions. The relationship between pain perception and endocrine effects suggests that hormones can be used as important biomarkers of chronic pain syndromes and/or be developed into therapeutic agents in the fight against pain.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Nijs J, Torres-Cueco R, van Wilgen CP, et al, 2014 Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Physician 17: 447–457.
Smart KM, Blake C, Staines A, Thacker M, Doody C, 2012 Mechanisms-based classifications of musculoskeletal pain: part 2 of 3: symptoms and signs of peripheral neuropathic pain in patients with low back (+/− leg) pain. Man Ther 17: 345–351.
Woolf CJ, 2011 Central sensitization: implications for the diagnosis and treatment of pain. Pain 152:Suppl 3: 2–15.
Mains RE, Eipper BA, Ling N, 1977 Common precursor to corticotropins and endorphins. Proc Natl Acad Sci USA 74: 3014–3018.
Roberts JL, Herbert E, 1977 Characterization of a common precursor to corticotropin and beta-lipotropin: cell-free synthesis of the precursor and identification of corticotropin peptides in the molecule. Proc Natl Acad Sci USA 74: 4826–4830.
Loh HH, Tseng LF, Wei E, Li CH, 1976 beta-endorphin is a potent analgesic agent. Proc Natl Acad Sci USA 73: 2895–2898.
Hartwig AC, 1991 Peripheral beta-endorphin and pain modulation. Anesth Prog 38: 75–78.
Mousa SA, Shakibaei M, Sitte N, Schafer M, Stein C, 2004 Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 145: 1331–1341.
Mastorakos G, Pavlatou MG, Mizamtsidi M, 2006 The hypothalamic-pituitary-adrenal and the hypothalamic-pituitary-gonadal axes interplay. Pediatr Endocrinol Rev 3:Suppl 1: 172–181.
Makman MH, Bilfinger TV, Stefano GB, 1995 Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and Chemotaxis. J Immunol 154: 1323–1330.
Cabot PJ, Carter L, Gaiddon C, et al, 1997 Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest 100: 142–148.
Simpkins CO, Dickey CA, Fink MP, 1984 Human neutrophil migration is enhanced by beta-endorphin. Life Sci 34: 2251–2255.
Kapitzke D, Vetter I, Cabot PJ, 2005 Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control. Ther Clin Risk Manag 1: 279–297.
Levine JD, Gordon NC, Fields HL, 1979 Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature 278: 740–741.
Corder G, Doolen S, Donahue RR, et al, 2013 Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science 341: 1394–1399.
Pereira MP, Donahue RR, Dahl JB, Werner M, Taylor BK, Werner MU, 2015 Endogenous Opioid-Masked Latent Pain Sensitization: Studies from Mouse to Human. PLoS One 10: e0134441.
Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L, 2011 A comprehensive review of opioid-induced hyperalgesia. Pain Physician 14: 145–161.
Qin ZL, Yang LQ, Li N, et al, 2016 Clinical study of cerebrospinal fluid neuropeptides in patients with primary trigeminal neuralgia. Clin Neurol Neurosurg 143: 111–115.
Jadric R, Kiseljakovic E, Hasic S, Winterhalter-Jadric M, 2007 Beta-endorphins as possible markers for therapeutic drug monitoring. Bosn J Basic Med Sci 7: 11–14.
Bruehl S, Burns JW, Chung OY, Chont M, 2012 What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function? Eur J Pain 16: 370–380.
Bruehl S, Burns JW, Gupta R, et al, 2016 Do Resting Plasma Beta-Endorphin Levels Predict Responses to Opioid Analgesics? Clin J Pain [Epub ahead of print].
Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER, 1998 Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 25: 1374–1381.
Cleare AJ, 2004 The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab 15: 55–59.
Chang L, Sundaresh S, Elliott J, et al, 2009 Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 21: 149–159.
Blackburn-Munro G, Blackburn-Munro RE, 2001 Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol 13: 1009–1023.
Ulrich-Lai YM, Xie W, Meij JT, Dolgas CM, Yu L, Herman JP, 2006 Limbic and HPA axis function in an animal model of chronic neuropathic pain. Physiol Behav 88: 67–76.
Kloppenburg M, Dijkmans BA, Rasker JJ, 1993 Effect of therapy for thyroid dysfunction on musculoskeletal symptoms. Clinical Rheumatol 12: 341–345.
Hagen K, Bjoro T, Zwart JA, Vatten L, Stovner LJ, Bovim G, 2001 Low headache prevalence amongst women with high TSH values. Eur J Neurol 8: 693–699.
Neeck G, Crofford LJ, 2000 Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 26: 989–1002.
Alves IG, da Cruz KM, Mota CM, et al, 2013 Experimental hypothyroidism during pregnancy affects nociception and locomotor performance of offspring in rats. Eur J Pain 17: 1291–1298.
Dussault JH, Ruel J, 1987 Thyroid hormones and brain development. Annu Rev Physiol 49: 321–334.
Bernal J, 2002 Action of thyroid hormone in brain. J Endocrinol Invest 25: 268–288.
Aloisi AM, Vodo S, Buonocore M, 2013 Pain and thyroid hormones. Neurol Sci 34: 1501–1508.
Narita M, Niikura K, Nanjo-Niikura K, et al, 2011 Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex. Pain 152: 1358–1372.
Dickenson AH, 1996 Balances between excitatory and inhibitory events in the spinal cord and chronic pain. Prog Brain Res 110: 225–231.
Wiens SC, Trudeau VL, 2006 Thyroid hormone and gamma-aminobutyric acid (GABA) interactions in neuroendocrine systems. Comp Bioch Physiol A Mol Integr Physiol 144: 332–344.
McCarberg BH, 2012 Clinical overview of fibromyalgia. Am J Ther 19: 357–368.
Lipton RB, Stewart WF, Scher AI, 2001 Epidemiology and economic impact of migraine. Curr Med Res Opin 17:Suppl 1: 4–12.
Flier SN, Rose S, 2006 Is functional dyspepsia of particular concern in women? A review of gender differences in epidemiology, pathophysiologic mechanisms, clinical presentation, and management. Am J Gastroenderol 101: 12 Suppl: 644–653.
Walker EA, Gelfand AN, Gelfand MD, Green C, Katon WJ, Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome. J Psychosom Obstet Gynaecol 17: 39–46.
Dinos S, Khoshaba B, Ashby D, et al, 2009 A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. Int J Epidemiol 38: 1554–1570.
Grigoriadis S, Robinson GE, 2007 Gender issues in depression. Ann Clin Psychiatry 19: 247–255.
Meleine M, Matricon J, 2014 Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. World J Gastroenterol 20: 6725–6743.
Iacovides S, Avidon I, Baker FC, 2015 Women with dysmenorrhoea are hypersensitive to experimentally induced forearm ischaemia during painful menstruation and during the pain-free follicular phase. Eur J Pain 19: 797–804.
Lee CW, Ho IK, 2013 Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors. Mol Pain 9: 45.
Vincent K, Warnaby C, Stagg CJ, Moore J, Kennedy S, Tracey I, 2013 Brain imaging reveals that engagement of descending inhibitory pain pathways in healthy women in a low endogenous estradiol state varies with testosterone. Pain 154: 515–524.
Aloisi AM, Bachiocco V, Costantino A, et al, 2007 Cross-sex hormone administration changes pain in transsexual women and men. Pain 132: Suppl 1: 60–67.
Bartley EJ, Fillingim RB, 2013 Sex differences in pain: a brief review of clinical and experimental findings. Br JAnaesth 111: 52–58.
Veldhuijzen DS, Keaser ML, Traub DS, Zhuo J, Gullapalli RP, Greenspan JD, 2013 The role of circulating sex hormones in menstrual cycle-dependent modulation of pain-related brain activation. Pain 154: 548–559.
White HD, Robinson TD, 2015 A novel use for testosterone to treat central sensitization of chronic pain in fibromyalgia patients. Int Immunopharmacol 27: 244–248.
Lakin ML, Miller CH, Stott ML, Winters WD, 1981 Involvement of the pineal gland and melatonin in murine analgesia. Life Sci 29: 2543–2551.
Williams LM, Hannah LT, Hastings MH, Maywood ES, 1995 Melatonin receptors in the rat brain and pituitary. J Pineal Res 19: 173–177.
Ambriz-Tututi M, Rocha-Gonzalez HI, Cruz SL, Granados-Soto V, 2009 Melatonin: a hormone that modulates pain. Life Sci 84: 489–498.
Jeong JH, Choi KB, Yi BC, et al, 2000 Effects of extremely low frequency magnetic fields on pain thresholds in mice: roles of melatonin and opioids. J Auton Pharmacol 20: 259–264.
Shavali S, Ho B, Govitrapong P, et al, 2005 Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Ress Bull 64: 471–479.
Song L, Wu C, Zuo Y, 2015 Melatonin prevents morphine-induced hyperalgesia and tolerance in rats: role of protein kinase C and N-methyl-D-aspartate receptors. BMC Anesthesiol 15: 12.
Mauriz JL, Collado PS, Veneroso C, Reiter RJ, Gonzalez-Gallego J, 2013 A review of the molecular aspects of melatonin’s anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 54: 1–14.
Ulugol A, Dokmeci D, Guray G, Sapolyo N, Ozyigit F, Tamer M, 2006 Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: Possible involvements of the L-arginine-NO pathway and opioid system. Life Sci 78: 1592–1597.
Schomberg D, Miranpuri G, Duellman T, Crowell A, Vemuganti R, Resnick D, 2015 Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches. Metab Brain Dis 30: 645–658.
Deng YK, Ding JF, Liu J, Yang YY, 2015 Analgesic effects of melatonin on post-herpetic neuralgia. Int J Clin Exp Med 8: 5004–5009.
Vogler B, Rapoport AM, Tepper SJ, Sheftell F, Bigal ME, 2006 Role of melatonin in the pathophysiology of migraine: implications for treatment. CNS Drugs 20: 343–350.
Yamamoto H, Tang H, 1998 Effects of 2-amino-7-phosphonohepatanoic acid, melatonin or NG-nitro-L-arginine on cyanide or N-methyl-D-aspartate-induced neurotoxicity in rat cortical cells. Toxicol Lett 94: 13–18.
Wikner J, Hirsch U, Wetterberg L, Rojdmark S, 1998 Fibromyalgia—a syndrome associated with decreased nocturnal melatonin secretion. Clin Endocrinol (Oxf) 49: 179–183.
Knook L, Kavelaars A, Sinnema G, Kuis W, Heijnen CJ, 2000 High nocturnal melatonin in adolescents with chronic fatigue syndrome. J Clin Endocrinol Metab 85: 3690–3692.
Radwan P, Skrzydlo-Radomanska B, Radwan-Kwiatek K, Burak-Czapiuk B, Strzemecka J, 2009 Is melatonin involved in the irritable bowel syndrome? J Physiol Pharmacol 60: Suppl 3: 67–70.
Copp DH, Cameron EC, 1961 Demonstration of a hypocalcemic factor (calcitonin) in commercial parathyroid extract. Science 134: 2038.
Austin LA, Heath H3rd, 1981 Calcitonin: physiology and pathophysiology. N Engl J Med 304: 269–278.
Knopp JA, Diner BM, Blitz M, Lyritis GP, Rowe BH, 2005 Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int 16: 1281–1290.
Jaeger H, Maier C, 1992 Calcitonin in phantom limb pain: a double-blind study. Pain 48: 21–27.
Zieleniewski W, 1990 Calcitonin nasal spray for painful diabetic neuropathy. Lancet 336: 449.
Appelboom T, 2002 Calcitonin in reflex sympathetic dystrophy syndrome and other painful conditions. Bone 30:Suppl 5: 84–86.
Gennari C, Chierichetti MS, Gonnelli S, Vibelli C, Montagnani M, Piolini M, 1986 Migraine prophylaxis with salmon calcitonin: a cross-over double-blind, placebo-controlled study. Headache 26: 13–16.
Martinez-Zapata MJ, Roque M, Alonso-Coello P, Catala E, 2006 Calcitonin for metastatic bone pain. Cochrane Database Syst Rev 19: CD003223.
Nakamoto H, Soeda Y, Takami S, Minami M, Satoh M, 2000 Localization of calcitonin receptor mRNA in the mouse brain: coexistence with serotonin transporter mRNA. Brain Res Mol Brain Res 76: 93–102.
Colado MI, Ormazabal MJ, Goicoechea C, Lopez F, Alfaro MJ, Martin MI, 1994 Involvement of central serotonergic pathways in analgesia elicited by salmon calcitonin in the mouse. Eur J Pharmacol 252: 291–297.
Laurian L, Oberman Z, Graf E, Gilad S, Hoerer E, Simantov R, 1986 Calcitonin induced increase in ACTH, beta-endorphin and Cortisol secretion. Horm Metab Res 18: 268–271.
Bhoi SK, Kalita J, Misra UK, 2012 Metabolic syndrome and insulin resistance in migraine. J Headache Pain 13: 321–326.
Seaman DR, 2013 Body mass index and musculoskeletal pain: is there a connection? Chiropr Man Therap 21: 15.
Greisen J, Juhl CB, Grofte T, Vilstrup H, Jensen TS, Schmitz O, 2001 Acute pain induces insulin resistance in humans. Anesthesiology 95: 578–584.
Chen WN, Lee CH, Lin SH, et al, 2014 Roles of ASIC3, TRPV1, and NaV1.8 in the transition from acute to chronic pain in a mouse model of fibromyalgia. Mol Pain 10: 40.
Berczi I, 1993 Prolactin, pregnancy and autoimmune disease. J Rheumatol 20: 1095–1100.
Polled A, Nappi G, Muriaido G, Bono G, Martignoni E, Savoldi F, 1982 Changes in the 24-hour prolactin pattern in cluster headache. Cephalalgia 2: 1–7.
Cavestro C, Rosatello A, Marino MP, Micca G, Asteggiano G, 2006 High prolactin levels as a worsening factor for migraine. J Headache Pain 7: 83–89.
Cuatrecasas G, Alegre C, Casanueva FF, 2014 GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment? Pituitary 17: 277–283.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, X., Zhang, J. & Wang, X. Hormones in pain modulation and their clinical implications for pain control: a critical review. Hormones 15, 313–320 (2016). https://doi.org/10.14310/horm.2002.1696
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1696